Covid situation in control, no need to panic: PMC
Despite a noticeable uptick in the number of Covid-19 cases recently, Pune Municipal Corporation (PMC) officials claim that the situation in the city is under control and there is no need to panic. Civic officials said that existing Covid management protocols will continue to be followed.
On Monday, the PMC held a review meeting to assess the Covid-19 situation in the city. The meeting was chaired by additional municipal commissioner M J Pradeep Chandran, and attended by representatives from the PMC health department, public health officials, and the Rapid Response Task Force. Experts from key institutions such as the National Chemical Laboratory (NCL), National Institute of Virology (NIV), B J Medical College (BJMC), and private hospitals also attended the meeting, according to officials. The RRT members said that the current virus strain in circulation is mild and no deaths have been reported in the city. The PMC till date has sent 145 Covid samples for genome sequencing and no new variant has been found. Besides, patients hospitalised with influenza-like illness (ILI) and severe acute respiratory infection (SARI) will be tested for Covid.
Dr Nina Borade, health chief of the PMC, said, 'The Covid situation in the city is under control and the situation is not alarming. However, experts have stressed that individuals in high-risk categories, with existing co-morbid conditions should take precautions. We have asked all private hospitals to test SARI and ILI patients for Covid.'
As per the statement issued by the public health department, Maharashtra on Monday reported 65 fresh Covid cases with 26 from areas under the PMC, 22 from Mumbai, and two from areas under the Pimpri-Chinchwad Municipal Corporation (PCMC). Since January, 1,504 Covid cases and 18 deaths amongst the infected have been reported. Furthermore, there are 613 active Covid-19 cases in the state. Since January, Mumbai has reported 687 cases, 681 of which were reported in May alone, said Dr Babita Kamlapurkar, joint director of health services.
Dr Kamlapurkar said that instructions have been issued to all officers in the divisional, district, and municipal corporations across the state during the Covid-19 review meeting. 'Surveillance for ILI and SARI patients is being conducted regularly, with 5% of these patients being asked to undergo testing for Covid-19. All Covid-positive samples are sent for whole genome sequencing. Additionally, all healthcare facilities under the public health department, medical colleges within the medical education department, and hospitals and medical colleges in urban areas are directed to be prepared for Covid-19 testing and treatment,' she said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
5 hours ago
- Time of India
Drug offers 99.9% HIV shield, but Indians will have to wait
Mumbai: A new drug promising 99.9% protection against HIV received approval from the US Food & Drug Administration (FDA) a few days ago, but the city's HIV rights activists are sceptical about its practical impact in India. The main concern stems from the new injectable drug lenacapavir's substantial cost of Rs 24 lakh ($28,218) per person for two injections taken six months apart. Also, NACO (National AIDS Control Organisation) has not fully embraced PrEP (pre-exposure prophylaxis) medications, the category to which lenacapavir belongs. "Our govt distributes condoms to break HIV transmission, it provides antiretroviral therapy drugs to prevent parent-to-child transmission of HIV, but it hasn't ever given PrEP to youngsters who are likely to indulge in high-risk behaviour," said health activist Ganesh Acharya. A couple of years ago, NACO made it mandatory for its counselling centres to disburse information on PrEP. He is alarmed because 75% of the 88% diagnosed with HIV in Mumbai between 2023-24 were in the 15-49 age group that is classified as young. PrEP is available for those seeking treatment in the private sector. PrEP, as a method to prevent HIV transmission before a risky exposure, has been around for almost 12 years. It was widely accepted in developed countries, but India's public health machinery never mentioned it until a few years ago. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo "They set up a committee, then a white paper was brought out that served as a backgrounder for guidelines that were drawn up last year. However, there has been no development since," said a doctor with a public hospital. Dr Ishwar Gilada of the People's Health Organisation (India) said PrEP is the lesser evil compared to HIV transmission. "The govt should distribute PrEP to check the spread of the disease, which has only been increasing in recent years. The total number of HIV-positive people in India increased from 2.2 million to 2.5 million in a few years," he added. The problem is more pronounced in Mumbai, he said, where the number of people with sexually transmitted diseases has been rising. "A recent survey in Mumbai among men who have sex with men found that 60% of them were positive for the human papilloma virus. While gonorrhoea and chlamydia vanished 25 years ago, their numbers are shooting up," said Dr Gilada. PrEP would be the solution, according to him. The govt could adopt a three-tier payment system for PrEP: Charge full cost from those who can afford it, subsidy for some, and free for those who cannot afford medications. Despite efforts, NACO officials were not available for comment. PrEP is not the only HIV-related policy that the govt hasn't acted on. Self-testing HIV kits, for instance, are not allowed in India. "We have self-testing kits for pregnancy, diabetes, and Covid, but policymakers fear about the mental health of people after a positive result in self-testing HIV kits," said Dr Gilada. The same logic is possibly behind the delay with introducing PrEP in the public health system, said a senior doctor, as a section of public health officials fear that giving PrEP would seem like a licence for risky behaviour. However, there is hope that lenacapavir would be available in India sooner rather than later. Bala of Bombay Gay said lenacapavir is a "monumental milestone forward in HIV treatment and prevention," but its pricing makes it inaccessible to Indian patients. "So, we have to wait and see if prices will come down over time," he added. Dr Gilada is positive Indian generic pharma companies licensed by Gilead Sciences can bring lenacapavir injections at below $100 per annum cost and may be rolled out soon. "India can do it," he said. In a statement released a couple of days ago, UNAIDS urged Gilead Lifesciences to drop the price of the new HIV prevention shot.
Time of India
9 hours ago
- Time of India
Four test positive for Covid-19
Four men tested positive for Covid-19 in the city on Saturday. The new cases include an 85-year-old from Telibagh, a 38-year-old, a 58-year-old from Mohanlalganj, and a 19-year-old from Chowk. With these additions, the total number of Covid-positive patients reported in the district reached 66, of which 35 are currently active.
Time of India
10 hours ago
- Time of India
Deadline diet India's young workforce faces cardiac scare
Young Indians are increasingly facing heart issues. Doctors report a rise in cardiac cases among those in their 20s and 30s. Stress, lack of sleep, and unhealthy lifestyles are major factors. Sedentary jobs and poor diets contribute to the problem. Even post-Covid inflammation increases the risk. Sales of heart-related drugs have significantly increased. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads For 31-year-old techie Kumar, long hours at work carrying well into the night often led to stress eating, coupled with an occasional drink (or two) to "take off the edge".The excesses magnified over the weekend, till one day when what he suspected was an episode of indigestion turned out to be a heart attack. Kumar, who doesn't want to reveal his full name, has now been put on a strict diet by his doctor. He has been asked to cut out all unhealthy food, stop eating out and is not an isolated case. Leading cardiologists are sounding the alarm bells as they see an increase in people in their 20s and 30s being hospitalised for cardiac issues. Stress, lack of sleep, pollution and working at odd hours have all contributed to the increase in heart disease among young people, said noted cardiologist Naresh Trehan."The numbers are worrisome; out of 34 beds in my ICU, nine are occupied by patients under 40," said Naveen Bhamri, vice-chairman of cardiology at Max Super Speciality Hospital in New Delhi's Shalimar Bagh, who performed an angioplasty on a 39-year-old this week. "A majority of my patients are in their 20s and 30s, who see long periods of inactivity due to being stuck at their desks, stressed out by the constant urban hustle and pressure to hit corporate targets."Nishith Chandra, director, interventional cardiology at Fortis Escorts Heart Institute in the national capital, said he is seeing 10-20 patients in the age group of 20-30 years every month with heart-related key drivers behind this trend are sedentary lifestyle, lack of exercise, high stress, poor sleep and mental health issues, Chandra said. "Undiagnosed hypertension, post-Covid heart inflammation, use of steroids and unsafe gym supplements, smoking, alcohol and recreational drug use are some other factors," he across the country are reporting increased cases of young professionals having cardiovascular diseases, sudden cardiac arrests and heart attacks."Not all of them have the typical triggers like diabetes, hypertension, obesity and family history. Recent data shows that one in four individuals having heart attacks are aged 40 and under," said M Sudhakar Rao, consultant - cardiology at Manipal Hospital, Sarjapur, Bengaluru Tight deadlines and work pressure, constant hustle culture and impending burnout are causing Indian professionals to remain in sedentary positions for most of the day, get less sleep, and turn to unhealthy, processed foods - all of which can contribute significantly to the risk of heart attacks, say medical is the diabetes and hypertension capital of the world, and people are genetically more predisposed to getting heart diseases, often earlier than their counterparts in the West, said Mukesh Goel, senior consultant - cardiothoracic and heart and lung transplant surgery at Delhi's Indraprastha Apollo Hospitals. "There's a difference of 10-15 years with the West."Telehealth consultation data from Plum shows two-thirds of cardiac consultations come from the 25-40 age group, showing a premature cardiovascular ageing in India's prime working demographic."We've observed that 71% of Indian working professionals are at moderate risk of chronic disease, showing warning signs across blood pressure, diabetes, cholesterol and obesity," Saurabh Arora, cofounder of the insurtech startup, told has increased the risk further, said Trehan. "People who got serious Covid actually have much higher chance of developing heart disease because there is inflammation of the arteries, and the heart muscle became weak. So, if those who got serious Covid were not checked out then they should get it now".Sales of drugs in the cardiac category have risen almost 50% in five years to ₹30,723 crore in the 12 months through May 2025, according to data from market research firm PharmaTrac."Consumption of lipid-lowering agents, antianginal therapies and heart failure therapies have almost doubled in the last five years with Indians experiencing heart disease 5-10 years earlier than the global average. The age group has now come down to 30-40 years from earlier 50-60 years, said Sheetal Sapale, vice-president, commercial at of cardiac products increased 11.7% in 2024 compared with the year before.
